The Oxford University AstraZeneca Covid-19 vaccine trial has been paused – should we be worried?
Is this the end for hopes of an early breakthrough in the race to find a coronavirus drug? The halt in development of the University […]
Infectious Diseases
Oxford University Covid vaccine trial put on hold due to possible adverse reaction in participant
A spokesman for AstraZeneca, the company working on the coronavirus vaccine, said pausing trials was common during vaccine development The development of a promising Covid-19 […]
Preparing For the Vaccine Results
So let’s take a few minutes to think about what happens when the vaccine trials start to read out. I’m making the assumption that the […]
AstraZeneca starts Covid-19 antibody drug trial in UK
Volunteers are receiving doses of drug, which has potential both as a vaccine and a treatment Coronavirus – latest updates See all our coronavirus coverage […]
Six of the most promising treatments for Covid-19 so far
While a cure-all drug or therapy is a long way off, there have been some breakthroughs Many different drugs and therapies are being trialled and […]
Oxford University Covid-19 vaccine firm denies Trump talks
AstraZeneca says it has not discussed ‘emergency use authorisation’ with the US Coronavirus – latest updates See all our coronavirus coverage The company manufacturing the […]
Coronavirus pharma news round-up 21/08/20
New insights into smell and taste loss symptoms, artificial intelligence and further encouraging data from a vaccine candidate hit the headlines this week as the […]
Pfizer/BioNTech say COVID-19 jab on track for approval by year-end
Pfizer and BioNTech have said their COVID-19 vaccine could be ready for regulators to review by October and approved by the end of the year […]
Here’s everything you need to know about the potential Oxford University Covid vaccine
The vaccine is designed to mimic the coronavirus and train the immune system to react if a person is later infected Sign up for Guardian […]
Smell and taste loss could help identify COVID-19 at airports, say researchers
Smell and taste loss associated with COVID-19 differs from that experienced by patients with common colds or flu, according to researchers who said the symptom […]
Encouraging News About Coronavirus Immunity
We’ve had some good news on coronavirus immunity recently – good because it gives us some more clarity on the whole situation, and because it […]
Could AI avert a future coronavirus pandemic?
Could AI prevent future pandemics by developing an armoury of drugs that work against all coronaviruses? This is a question that a consortium of European […]
UK signs coronavirus vaccine deals with J&J and Novavax
The UK is to buy millions more doses of potential coronavirus vaccines from Johnson & Johnson and Novavax, with the latter expanding its manufacturing operation […]
UK agrees deals for 90m doses of two potential coronavirus vaccines
Government secures early access to those being developed by Novavax and Janssen Coronavirus – latest updates See all our coronavirus coverage The UK government has […]
Around 3.4m people infected with coronavirus in England – study
Just under 6% of England’s population – around 3.4 million people – had been infected with coronavirus by the end of June according to an […]
Scepticism as Russia claims coronavirus vaccine breakthrough with Sputnik V
Russia has become the first country in the world to approve a coronavirus vaccine, amid scepticism from international experts who have been unable to review […]
The Russian Vaccine
Many will have heard Russia’s announcement that they have approved a coronavirus vaccine. I’ve already had several people ask me what I think of it, […]
Gilead files COVID-19 drug remdesivir with FDA
Gilead has filed its COVID-19 drug remdesivir with the FDA, to treat patients with severe disease, under the brand name Veklury. The drug is currently […]
The Guardian view on Brexit bureaucracy: tied up in red tape | Editorial
Businesses already struggling with the fallout from Covid-19 will be forced to deal with a mountain of new bureaucracy in the middle of a deep […]
Pfizer signs deal with Gilead to manufacture COVID-19 antiviral remdesivir
Pfizer has signed a multi-year agreement with Gilead to manufacture and supply the COVID-19 antiviral remdesivir, which is also being tested in combination with other […]
Vaccine Data From Novavax
Several days after making some headlines with a press release about the data, the Novavax vaccine effort has published on Medrxiv. The is the first […]
Novavax says COVID-19 vaccine could be approved by year-end
Novavax’s COVID-19 vaccine produced higher levels of neutralising antibodies than produced by recovered patients in an early trial, paving the way for a phase 3 […]
Regeneron’s Monoclonal Antibody Cocktail in Primates
I’m very glad to see some data emerging on the monoclonal antibody therapies that have been in the works. Regeneron and Eli Lilly/Abcellera are two […]
Covid-19: Gilead Sciences urged to study drug that showed promise with cats
Activists accuse company of pushing remdesivir to boost profit GS-441524 has been used to treat a coronavirus in cats Coronavirus – latest global updates Activists […]
Gilead loses $3.3bn in Q2, blaming COVID-19 and cancer drugs firm acquisition
Gilead has blamed a $3.3 billion loss in Q2 on its acquisition of immune-oncology company Forty Seven – but revenues are declining as the pandemic […]
Coronavirus Challenges in Primates, Compared
We have a sudden influx over the last few days of preclinical rhesus challenge studies with various coronavirus vaccines, and it’s only natural to try […]
Understanding COVID-19 and varying responses across the globe
While lockdown eases across England, local lockdowns are becoming an ever-growing threat across the country. This is a unique response in comparison to other countries […]
Coronavirus: UK signs deal for 60m doses of potential vaccine
GlaxoSmithKline and Sanofi Pasteur could supply vaccine by early next year if it is successful Coronavirus – latest updates See all our coronavirus coverage The […]
Covid-19 is Big Pharma’s chance to impress. But who’ll do best?
AstraZeneca and GSK both release results this week. But picking winners in the sector may be complicated It was the press announcement heard around the […]
‘Major’ breakthrough in Covid-19 drug makes UK professors millionaires
Synairgen’s share price rises 540% on morning of news of successful drugs trial Coronavirus – latest updates See all our coronavirus coverage Three professors at […]
The world needs a ‘people’s vaccine’ for coronavirus, not a big-pharma monopoly | Helen Clark and Winnie Byanyima
AstraZeneca and others should not own a lucrative patent on a medicine that is needed by poor as well as rich nations • See all […]
Bacteria and Colon Cancer
Let’s catch on some non-coronavirus research today with an interesting approach against a very bad disease, metastatic colon cancer. This new paper (from groups at […]
New report shows more than 400 medicines and vaccines in development to tackle infectious diseases, including COVID-19
Throughout history, infectious diseases caused by pathogens such as bacteria or viruses have taken a devastating toll on the lives and security of people around […]
New Data on the CanSino Vaccine
And now we have more data on the CanSino vaccine, another adenovirus vector (but this one using Ad5, a much more common one in the […]
New Data on the Oxford/AZ Vaccine
The hype began building late last week around the Oxford vaccine results released today, and I will confess to wondering just what was going on. […]
More Pfizer Phase I Results: Antibodies, Viral Mutations, and T Cells
Recent posts here have gone into Moderna’s Phase I vaccine data, Pfizer’s Phase I vaccine data, what we don’t know yet about the relationship between […]
One more weekend? GTA close to Stage 3 opening, officials say
The post One more weekend? GTA close to Stage 3 opening, officials say appeared first on Healthy Debate.
New Data on T Cells and the Coronavirus
Well, I was writing just the other day about what we don’t know about the T-cell response to coronavirus infection, and as of today we […]
Moderna’s Phase I Data
Well, it’s finally here – eight weeks to the day after press-releasing some top line results, the full paper is out on the Moderna mRNA […]
Pfizer’s Progress
I wanted to point out an interesting interview given by Pfizer’s CEO Albert Bourla to Time. I have made some pointed remarks about Pfizer over […]
More on T Cells, Antibody Levels, and Our Ignorance
I wrote here about the reports of rather short antibody persistence in recovering coronavirus patients, and what’s been coming out in the two weeks since […]
WHO says trials show malaria and HIV drugs don’t cut Covid-19 hospital deaths
Hydroxychloroquine and lopinavir/ritonavir not found to help patients in hospital Coronavirus – latest updates See all our coronavirus coverage The World Health Organization (WHO) said […]
Oxford offers best hope for Covid-19 vaccine this year, MPs told
University is leading rivals but first drugs may not work fully, says vaccine taskforce chair Coronavirus – latest updates See all our coronavirus coverage Oxford […]
Coronavirus Vaccine Update, July 7
More vaccine news to catch up on – previous updates and specific topic posts on this subject were on June 15, on June 11, on May […]
Demand for flu vaccine soars as countries plan for second Covid-19 wave
Manufacturers warn they will struggle to meet demand as governments seek to ease pressure on health services Coronavirus – latest updates See all our coronavirus […]
The Lancet’s editor: ‘The UK’s response to coronavirus is the greatest science policy failure for a generation’
Richard Horton does not hold back in his criticism of the UK’s response to the pandemic and the medical establishment’s part in backing fatal government […]
FLU-PRO©: InFLUenza Patient-Reported Outcome
Access the on-demand webinar now https://bit.ly/FLU-PRO The FLU-PRO is a self-administered patient-reported outcome measure (PRO) to quantify symptom severity in influenza and influenza-like illness. The […]
Healthcare Headlines: November 2019
<h2 class="heading-medium">Medicare Shared Savings ACOs Generated $1.7b In Savings In 2018 </h2> <p>CMS announced that the 2018 Medicare Shared Savings Program generated $1.7 billion in […]
